# Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study

> **NCT02650791** · PHASE3 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 100 (actual)

## Conditions studied

- Hematologic Neoplasms

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT02650791
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02650791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02650791, "Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02650791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*